Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TDAY | NYT |
|---|---|---|
| Price | $6.95 | $65.68 |
| Change today | ▼ 1.56% | ▲ 1.20% |
| Market cap | $1.02B | $10.59B |
| Return, 3 months | -17.7% | -11.6% |
| Return, year to date | +35.0% | -4.6% |
| Return, 1 year | +79.6% | +19.8% |
| P/E (TTM) | -33.1 | 27.4 |
| P/B | 6.6 | 5.2 |
| P/E percentile vs own 5y | 1st | 5th |
| Dividend yield | – | 1.17% |
| Revenue growth (YoY, latest qtr) | -8.3% | +11.2% |
| Net profit growth (YoY) | -88.3% | +12.6% |
| Gross margin | 39.5% | 51.4% |
| Operating margin | 6.7% | 16.6% |
| Net margin | -1.8% | 13.2% |
| Return on equity | -20.6% | 19.7% |
| Analyst target vs. price | +30.5% | +23.5% |
| Analyst buy share | 67% | 71% |
| RSI (14) | 58 | 47 |
| 30-day volatility | 46.6% | 37.8% |
| Max drawdown, 1 year | -31.6% | -27.7% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
